Search | TVST | ARVO Journals

Showing 1 – 20 of 23

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2017

Different characteristics predict good visual outcomes in patients with CRVO vs BRVO; hypertension is associated with good outcome in CRVO but not BRVO

Peter A Campochiaro; Raafay Sophie; Ann Clark; Na Lu; Carlos Quezada-Ruiz

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4626. doi:

ARVO Annual Meeting Abstract June 2015

Reduction of Macular Edema and Pro-permeability Factors after Dexamethasone Implant Injection in Retinal Vein Occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) Study

Tahreem Aman Mir; Gulnar Hafiz; Adrienne Scott; Raafay Sophie; Syed Mahmood Shah; Howard S Ying; Lu Lili; Connie J Chen; J Peter Campbell; Peter Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1282. doi:

Articles March 2015

Fixation Stability Measurement Using Two Types of Microperimetry Devices

PDF

Hongting Liu; Millena G. Bittencourt; Raafay Sophie; Yasir J. Sepah; Mostafa Hanout; Zubir Rentiya; Rachel Annam; Hendrik P. N. Scholl; Quan Dong Nguyen
TAGS: sample size, eye, macular disorders, significance
Trans. Vis. Sci. Tech.. 2015; 4(2):3. doi: 10.1167/tvst.4.2.3

Articles September 2014

Assessment of Central Retinal Sensitivity Employing Two Types of Microperimetry Devices

PDF

Hongting Liu; Millena G. Bittencourt; Jiangxia Wang; Raafay Sophie; Rachel Annam; Mohamed A. Ibrahim; Yasir J. Sepah; Ahmadreza Moradi; Hendrik P. N. Scholl; Quan Dong Nguyen
TAGS: mathematics, eye, microbiology procedure, macular disorders, significance, attenuation, luminance, ceiling effect, dynamic range
Trans. Vis. Sci. Tech.. 2014; 3(5):3. doi: 10.1167/tvst.3.5.3

ARVO Annual Meeting Abstract April 2014

Baseline predictors of functional outcomes in patients with diabetic macular edema (DME) in the RISE and RIDE trials

Raafay Sophie; Na Lu; Peter A Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1702. doi:

ARVO Annual Meeting Abstract April 2014

A Phase 1b/2a Open-Label, Multiple-Ascending Dose Cohort Study to Assess the Safety, Tolerability, Pilot Efficacy, Pharmacokinetics and Pharmacodynamic Effects of 28-Day Repeat Subcutaneous Doses of AKB-9778 in Subjects with Diabetic Macular Edema

Mitchell G Brigell; Peter A Campochiaro; Raafay Sophie; Michael Tolentino; Daniel Miller; David Browning; David S Boyer; Jeffrey S Heier; Kevin Peters

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1757. doi:

ARVO Annual Meeting Abstract April 2014

Contrast sensitivity evaluation in high-risk treatment-naïve proliferative diabetic retinopathy treated with panretinal photocoagulation with and without intravitreal Ranibizumab.

Daniel Araujo Ferraz; Lisa Vasquez; Augusto Motta; Rony C Preti; Raafay Sophie; Millena Gomes Bittencourt; Mario L R Monteiro; Walter Y Takahashi

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4414. doi:

ARVO Annual Meeting Abstract April 2014

Changes in retinal nonperfusion observed on ultra-widefield angiography in patients with retinal vein occlusion treated with ranibizumab

Hongting Liu; Tahreem A Mir; Olivia R Mitthivong; Raafay Sophie

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):276. doi:

ARVO Annual Meeting Abstract June 2013

Comparison of retinal layer thickness of normal eyes and eyes with diabetic macular edema receiving ranibizumab

Zubir Rentiya; Yasir Sepah; Mohamed Ibrahim; Mohammad Sadiq; Muhammad Hassan; Saleema Kherani; Hyun Soo Jang; Raafay Sophie; Diana Do; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3608. doi:

ARVO Annual Meeting Abstract June 2013

Retinal Thickness, Retinal Point Sensitivity and Inner Segment/Outer Segment Photoreceptor (IS/OS) Status after Treatment with Ranibizumab in Patients with Diabetic Macular Edema

Millena Bittencourt; Daniel Ferraz; Jithin Yohanan; Owhofasa Agbedia; Mohammad Sadiq; Yasir Sepah; Mohamed Ibrahim; Raafay Sophie; Mostafa Hanout; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3633. doi:

ARVO Annual Meeting Abstract June 2013

Longitudinal Changes in Retinal Sensitivity among Patients with Maculopathy

Hongting Liu; Millena Bittencourt; Owhofasa Agbedia; Ahmadreza Moradi; Yasir Sepah; Daniel Ferraz; Mohamed Ibrahim; Raafay Sophie; Mehreen Ansari; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5026. doi:

ARVO Annual Meeting Abstract June 2013

Retinal Vessel Caliber as a Predictor of Visual Outcome in Eyes with Diabetic Macular Edema (DME) Treated with Ranibizumab

Ahmadreza Moradi; Raafay Sophie; Rachel Annam; Owhofasa Agbedia; Hongting Liu; Mostafa Hanout; Millena Bittencourt; Mohamed Ibrahim; Diana Do; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):21. doi:

ARVO Annual Meeting Abstract June 2013

Variation of Choroidal Thickness and Choroidal Vessel Diameter in Patients with White Dot Syndromes

Saleema Kherani; Millena Bittencourt; Daniel Ferraz; Hongting Liu; Mehreen Ansari; Mohammad sadiq; Raafay Sophie; Rachel Annam; Yasir Sepah; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):27. doi:

ARVO Annual Meeting Abstract June 2013

Comparison of the Spectral Domain Optical Coherence Tomography Characteristics in Patients with Multifocal Choroiditis and Punctate Inner Choroidopathy

Roomasa Channa; Jiangxia Wang; Mohamed Ibrahim; Jeong Lee; Daniel Ferraz; Yasir Sepah; Millena Bittencourt; Raafay Sophie; Elham Hatef Naimi; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5375. doi:

ARVO Annual Meeting Abstract June 2013

Validation of the Precision of a Novel Representation of Images Obtained by the Optos P200Tx Ultra Wide-Field Imaging System

Natasha Maqsood; Raafay Sophie; Jano van Hemert; Derek Swan; Michael Verhoek; Millena Bittencourt; Daniel Ferraz; Hyun Soo Jang; Yasir Sepah; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5502. doi:

ARVO Annual Meeting Abstract June 2013

Reliability of Automated Leakage Quantification of Fluorescein Angiography in Eyes with Diabetic Macular Edema

Owhofasa Agbedia; Eman Magdy; Mohamed Ibrahim; Yasir Sepah; Raafay Sophie; Millena Bittencourt; Mostafa Hanout; Diana Do; Ahmed Fahmy; Quan Dong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5514. doi:

ARVO Annual Meeting Abstract June 2013

Intravitreal Ranibizumab Combined with Panretinal Photocoagulation in Patients with Treatment-Naive Proliferative Diabetic Retinopathy

Daniel Ferraz; Raafay Sophie; Millena Bittencourt; Rony Preti; Lisa Vazquez; Augusto Motta; Mostafa Hanout; Yasir Sepah; Quan Dong Nguyen; Walter Takahashi

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5761. doi:

ARVO Annual Meeting Abstract March 2012

Ranibizumab Dose Comparison (0.5mg And 2.0mg) And The Role Of Laser In The Management Of Retinal Vein Occlusion (RELATE) Trial Interim Report

Peter A. Campochiaro; Gulnar Hafiz; Raafay Sophie; Diana V. Do; Adrienne W. Scott; Quan D. Nguyen; Sharon Solomon; Akrit Sodhi; Elia Duh; Howard Ying

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):917. doi:

ARVO Annual Meeting Abstract March 2012

Five-Year Follow Up Of Ranibizumab For Retinal Vein Occlusion: Intermittent Treatment To Control Edema Does Not Prevent Progressive Worsening Of Retinal Nonperfusion

Raafay Sophie; Gulnar Hafiz; Diana V. Do; Quan D. Nguyen; Sharon Solomon; Ingrid Zimmer-Galler; Howard Ying; Adrienne W. Scott; David Baranano; Peter A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):918. doi:

ARVO Annual Meeting Abstract March 2012

Comparison of Fundus Autofluorescence Images Obtained by Two Different Wavelengths of Light in Normals, Myopic Subjects, and Patients with Retinochoroidopathy

Millena G. Bittencourt; Yasir J. Sepah; Mohhamed Ibrahim; Raafay Sophie; Owhofasa Agbedia; Abeer Akhtar; Hyun S. Jang; Jithin Yohannan; Diana V. Do; Quan D. Nguyen

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3108. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Different characteristics predict good visual outcomes in patients with CRVO vs BRVO; hypertension is associated with good outcome in CRVO but not BRVO

Reduction of Macular Edema and Pro-permeability Factors after Dexamethasone Implant Injection in Retinal Vein Occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) Study

Fixation Stability Measurement Using Two Types of Microperimetry Devices

Assessment of Central Retinal Sensitivity Employing Two Types of Microperimetry Devices

Baseline predictors of functional outcomes in patients with diabetic macular edema (DME) in the RISE and RIDE trials

A Phase 1b/2a Open-Label, Multiple-Ascending Dose Cohort Study to Assess the Safety, Tolerability, Pilot Efficacy, Pharmacokinetics and Pharmacodynamic Effects of 28-Day Repeat Subcutaneous Doses of AKB-9778 in Subjects with Diabetic Macular Edema

Contrast sensitivity evaluation in high-risk treatment-naïve proliferative diabetic retinopathy treated with panretinal photocoagulation with and without intravitreal Ranibizumab.

Changes in retinal nonperfusion observed on ultra-widefield angiography in patients with retinal vein occlusion treated with ranibizumab

Comparison of retinal layer thickness of normal eyes and eyes with diabetic macular edema receiving ranibizumab

Retinal Thickness, Retinal Point Sensitivity and Inner Segment/Outer Segment Photoreceptor (IS/OS) Status after Treatment with Ranibizumab in Patients with Diabetic Macular Edema

Longitudinal Changes in Retinal Sensitivity among Patients with Maculopathy

Retinal Vessel Caliber as a Predictor of Visual Outcome in Eyes with Diabetic Macular Edema (DME) Treated with Ranibizumab

Variation of Choroidal Thickness and Choroidal Vessel Diameter in Patients with White Dot Syndromes

Comparison of the Spectral Domain Optical Coherence Tomography Characteristics in Patients with Multifocal Choroiditis and Punctate Inner Choroidopathy

Validation of the Precision of a Novel Representation of Images Obtained by the Optos P200Tx Ultra Wide-Field Imaging System

Reliability of Automated Leakage Quantification of Fluorescein Angiography in Eyes with Diabetic Macular Edema

Intravitreal Ranibizumab Combined with Panretinal Photocoagulation in Patients with Treatment-Naive Proliferative Diabetic Retinopathy

Ranibizumab Dose Comparison (0.5mg And 2.0mg) And The Role Of Laser In The Management Of Retinal Vein Occlusion (RELATE) Trial Interim Report

Five-Year Follow Up Of Ranibizumab For Retinal Vein Occlusion: Intermittent Treatment To Control Edema Does Not Prevent Progressive Worsening Of Retinal Nonperfusion

Comparison of Fundus Autofluorescence Images Obtained by Two Different Wavelengths of Light in Normals, Myopic Subjects, and Patients with Retinochoroidopathy

To View More...

You must be signed into an individual account to use this feature.